Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders

Carbonic anhydrases (CAs, EC 4.2.1.1) are enzymes involved in a multitude of diseases, and their inhibitors are in clinical use as drugs for the management of glaucoma, epilepsy, obesity, and tumours. In the last decade, multitargeting approaches have been proposed by hybridisation of CA inhibitors...

Full description

Saved in:
Bibliographic Details
Main Author: Claudiu T. Supuran (Author)
Format: Book
Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_193d7f3a8b2943f6b1ca169a740031eb
042 |a dc 
100 1 0 |a Claudiu T. Supuran  |e author 
245 0 0 |a Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders 
260 |b Taylor & Francis Group,   |c 2021-01-01T00:00:00Z. 
500 |a 1475-6366 
500 |a 1475-6374 
500 |a 10.1080/14756366.2021.1945049 
520 |a Carbonic anhydrases (CAs, EC 4.2.1.1) are enzymes involved in a multitude of diseases, and their inhibitors are in clinical use as drugs for the management of glaucoma, epilepsy, obesity, and tumours. In the last decade, multitargeting approaches have been proposed by hybridisation of CA inhibitors (CAIs) of sulphonamide, coumarin, and sulphocoumarin types with NO donors, CO donors, prostaglandin analogs, β-adrenergic blockers, non-steroidal anti-inflammatory drugs, and a variety of anticancer agents (cytotoxic drugs, kinase/telomerase inhibitors, P-gp and thioredoxin inhibitors). Many of the obtained hybrids showed enhanced efficacy compared to the parent drugs, making multitargeting an effective and innovative approach for various pharmacological applications. 
546 |a EN 
690 |a carbonic anhydrase 
690 |a inhibitors 
690 |a hybrid drugs 
690 |a multitargeting 
690 |a anticancer agents 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 1702-1714 (2021) 
787 0 |n http://dx.doi.org/10.1080/14756366.2021.1945049 
787 0 |n https://doaj.org/toc/1475-6366 
787 0 |n https://doaj.org/toc/1475-6374 
856 4 1 |u https://doaj.org/article/193d7f3a8b2943f6b1ca169a740031eb  |z Connect to this object online.